Science Explorer Back to mapMap
Discussion
Company · Dundalk · Ireland

Teva Pharmaceuticals (Ireland)

Research works
5
▼ 10% vs 2018-21
Citations
96
18.2 per fractional work
Top-10% rate
16.7%
all institutions 10.0%
Open access
70%
world 40%
International
72%
world 18%

Not ranked overall: Teva Pharmaceuticals (Ireland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Teva Pharmaceuticals (Ireland) work in?

In all years, 68% of research at Teva Pharmaceuticals (Ireland) is in Health Sciences, 19% in Physical Sciences. Its largest fields are Medicine (68%), Engineering (11%), Earth and Planetary Sciences (7%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 68.4% of its workMedicine: 4 fractional works · 68.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 28.9% of its workInfectious Diseases: 1 fractional works · 21.7% of its workPhysiology: 0 fractional works · 4.2% of its workHepatology: 0 fractional works · 3.6% of its workPsychiatry and Mental health: 0 fractional works · 3.6% of its workOncology: 0 fractional works · 2.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 2.1% of its workEpidemiology: 0 fractional works · 1.3% of its workHematology: 0 fractional works · 0.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 18.7% of its workEngineering: 1 fractional works · 10.6% of its workOcean Engineering: 0 fractional works · 5.3% of its workComputational Mechanics: 0 fractional works · 4.0% of its workBiomedical Engineering: 0 fractional works · 1.3% of its workEarth and Planetary Sciences: 0 fractional works · 6.8% of its workGeophysics: 0 fractional works · 5.5% of its workPaleontology: 0 fractional works · 1.3% of its workComputer Science: 0 fractional works · 1.3% of its workArtificial Intelligence: 0 fractional works · 1.3% of its workLife Sciences: 1 fractional works · 11.9% of its workAgricultural and Biological Sciences: 0 fractional works · 3.2% of its workPlant Science: 0 fractional works · 3.2% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 2.6% of its workMolecular Biology: 0 fractional works · 2.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.6% of its workPharmacology: 0 fractional works · 1.5% of its workPharmaceutical Science: 0 fractional works · 1.1% of its workNeuroscience: 0 fractional works · 1.9% of its workBiological Psychiatry: 0 fractional works · 0.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workImmunology: 0 fractional works · 1.5% of its workSocial Sciences: 0 fractional works · 0.9% of its workDecision Sciences: 0 fractional works · 0.9% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.9% of its workALL ITS WORKTevaPharmaceuticals…5fractional works, all years
Life Sciences12%Physical Sciences19%Health Sciences68%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine468.4%
    1. Engineering110.6%
    2. Earth and Planetary Sciences06.8%
    3. Computer Science01.3%
    1. Agricultural and Biological Sciences03.2%
    2. Biochemistry, Genetics and Molecular Biology02.6%
    3. Pharmacology, Toxicology and Pharmaceutics02.6%
    4. Neuroscience01.9%
    5. Immunology and Microbiology01.5%
    1. Decision Sciences00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.33× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 0.73× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 13.81× its world share, 0 worksPharmacology, Toxico…Earth and Planetary Sciences: 12.41× its world share, 0 worksEarth and Planetary …Engineering: 1.32× its world share, 0 worksEngineeringMedicine: 2.01× its world share, 0 worksMedicineDecision Sciences: 4.32× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.8×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics13.81×0 works
  2. Earth and Planetary Sciences12.41×0 works
  3. Decision Sciences4.32×0 works
  4. Biochemistry, Genetics and Molecular Biology2.33×0 works
  5. Medicine2.01×0 works
  6. Engineering1.32×0 works
  7. Immunology and Microbiology0.73×0 works

What are the most cited papers from Teva Pharmaceuticals (Ireland)?

The most cited paper from Teva Pharmaceuticals (Ireland) is "Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients" (Henk W. Reesink, Gregory C. Fanning, Khalid Abou Farha et al., 2009), with 156 citations. Next come "Rapid Viral Response of Once-Daily Tmc435 plus Pegylated Interferon/Ribavirin in Hepatitis C Genotype-1 Patients: A Randomized Trial" (66) and "A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites" (61).

Most cited papers
#PaperReleasedCitations
1 Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients Henk W. Reesink, Gregory C. Fanning, Khalid Abou Farha et al. · Gastroenterology 22 Oct 2009 156
2 Rapid Viral Response of Once-Daily Tmc435 plus Pegylated Interferon/Ribavirin in Hepatitis C Genotype-1 Patients: A Randomized Trial Michael Peter Manns, Henk W. Reesink, Thomas Berg et al. · Antiviral Therapy Open access 9 Sep 2011 66
3 A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites Shaowei Zhang, Michiyo Sakuma, Girdhar Singh Deora et al. · Communications Biology Open access 24 Jul 2019 61
4 Targeted Delivery of 5-Fluorouracil and Sonidegib via Surface-Modified ZIF-8 MOFs for Effective Basal Cell Carcinoma Therapy Bharath Singh Padya, Gasper J. Fernandes, Sumukha Hegde et al. · Pharmaceutics Open access 7 Nov 2023 35
5 ProAir ® HFA Delivers Warmer, Lower-Impact, Longer-Duration Plumes Containing Higher Fine Particle Dose Than Ventolin ® HFA Jacquelyn Cruz McCabe, Franciscus Koppenhagen, Julian M. Blair et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 22 Dec 2011 24
All 15 most cited papers, with filters and sorting

Which research topics does Teva Pharmaceuticals (Ireland) publish most on?

By volume in 2022-now: Inhalation and Respiratory Drug Delivery, Seismic Imaging and Inversion Techniques, Nanoplatforms for cancer theranostics and Migraine and Headache Studies.

  1. 1 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  2. 2 Seismic Imaging and Inversion Techniques Geophysics 0 works
  3. 3 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  4. 4 Migraine and Headache Studies Psychiatry and Mental health 0 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 0 works
  6. 6 Fibroblast Growth Factor Research Molecular Biology 0 works
  7. 7 Seismic Waves and Analysis Geophysics 0 works
  8. 8 Geophysical Methods and Applications Ocean Engineering 0 works
  9. 9 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available70.2%not open29.8%

World: 40% of research is openly available.

with international co-authors71.5%domestic only28.5%

World: 18% is written across borders.

How has Teva Pharmaceuticals (Ireland)'s research output changed?

Output in 2022-2025 was 10% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Teva Pharmaceuticals (Ireland) as a percentage of every work published that year, 0.0000063% in 2023.

still counting0.000020%0.000040%0.000060%Teva Pharmaceuticals (Ireland)0.0000068% in 202520102020

Fractional works of Teva Pharmaceuticals (Ireland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Dundalk

All research institutions in Dundalk

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Teva Pharmaceuticals (Ireland). Posts are plain text and can be reported.